Health Technology Assessment on Insulin Analogue as Treatment for Type 2 Diabetes in Indonesia

Jan. 21, 2019

Almost every diabetic patient in Indonesia that requires insulin to control their blood sugar is treated with the newer generation insulin analogue, despite internationally recognized guidance that low and middle-income countries (LMICs) should aim to use the less costly human insulin, the first generation of man-made insulin, as a first line treatment.